author-photo

Mark Clemons

University of Ottawa
Ottawa Hospital Research Institute
Ottawa Hospital

479

Papers

10050

Citations

Citation Trend

Filter By

Papers (479) Sort By

Journal Conference Others

Adjuvant bisphosphonate use in patients with early stage breast cancer: Patient perspectives on treatment acceptability and potential de-escalation

2021 Journal of bone oncology
Show All
- Source
- Cite
- Save
Citations (2)
Abstract PS9-47: A scoping review characterizing “choosing wisely” recommendations for breast cancer management

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Perceptions around bone-modifying agent use in patients with bone metastases from breast and castration resistant prostate cancer: a patient survey.

2021 Supportive Care in Cancer
Show All
- Source
- Cite
- Save
Citations (3)
Does the Time of Day at Which Endocrine Therapy Is Taken Affect Breast Cancer Patient Outcomes

2021 Current Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Clinical utility of a prediction tool to differentiate between breast cancer patients at high or low risk of chemotherapy-induced nausea and vomiting

2021 Supportive Care in Cancer
Show All
- Source
- Cite
- Save
Citations (1)
Impact of the menstrual cycle on commercial prognostic gene signatures in oestrogen receptor-positive primary breast cancer.

2021 Breast Cancer Research and Treatment
Show All
- Source
- Cite
- Save
Citations (0)
Abstract PS14-18: A physician survey evaluating real-world practice patterns and attitudes towards de-escalation of bone-modifying agents in patients with bone metastases from breast cancer

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Neoadjuvant Chemotherapy in Breast Cancer: Review of the Evidence and Conditions That Facilitated Its Use during the Global Pandemic.

2021 Current Oncology
Show All
- Source
- Cite
- Save
Citations (1)
A multi-centre study comparing granulocyte-colony stimulating factors to antibiotics for primary prophylaxis of docetaxel-cyclophosphamide induced febrile neutropenia

2021 The Breast
Show All
- Source
- Cite
- Save
Citations (1)
Two-year results of a randomised trial comparing 4- versus 12-weekly bone-targeted agent use in patients with bone metastases from breast or castration-resistant prostate cancer.

2021 Journal of bone oncology
Show All
- Source
- Cite
- Save
Citations (1)